Moreover, miR-92 is the only miRNA from the miR-17-92 cluster with a significant differential expression between MYCN amplified and MYCN single copy tumor samples (Mann-Whitney, Benjamini-Hochberg multiple testing correction, P < 0.05). This evidence concerns the gene MYCN and neoplasm.